Chi-Med Highlights Oral Presentations on Savolitinib Lung Cancer Programs at AACR Annual Meeting

NEXT STORY
Philips re-aligns its ‘Lives Improved’ target with the UN 2030 Sustainable Development Agenda following the completion of its portfolio transformation
PREV STORY
Bavarian Nordic A/S – Notice Convening Ordinary General Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex Expands its Strategic Partnership with Guangzhou Xiangxue Pharmaceutical Through a Licensing Agreement for its Product Candidates Oral Paclitaxel and Oral Irinotecan, as well as Tirbanibulin Ointment, in China, Hong Kong and Macao

author_avatar
NASDAQ Market News

Globus Medical Premieres ANTHEM® Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting

author_avatar
NASDAQ Market News

Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.

author_avatar
NASDAQ Market News